Skip to main content
Top
Published in: BMC Health Services Research 1/2020

Open Access 01-12-2020 | Antibiotic | Research article

Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014–2017: a longitudinal analysis of electronic health record data

Authors: M. Z. Raban, K. E. Lind, R. O. Day, L. Gray, A. Georgiou, J. I. Westbrook

Published in: BMC Health Services Research | Issue 1/2020

Login to get access

Abstract

Background

Internationally, point prevalence surveys are the main source of antibiotic use data in residential aged care (RAC). Our objective was to describe temporal trends in antibiotic use and antibiotics flagged for restricted use, resident characteristics associated with use, and variation in use by RAC home, using electronic health record data.

Methods

We conducted a retrospective cohort study of 9793 unique residents aged ≥65 years in 68 RAC homes between September 2014 and September 2017, using electronic health records. We modelled the primary outcome of days of antibiotic therapy /1000 resident days (DOT/1000 days), and secondary outcomes of number of courses/1000 days and the annual prevalence of antibiotic use. Antibiotic use was examined for all antibiotics and antibiotics on the World Health Organization’s (WHO) Watch List (i.e. antibiotics flagged for restricted use).

Results

In 2017, there were 85 DOT/1000 days (99% CI: 79, 92), 8.0 courses/1000 days (99% CI: 7.6, 8.5), and 63.4% (99% CI: 61.9, 65.0) of residents received at least one course of antibiotics. There were 7.7 DOT/1000 days (99% CI: 6.69, 8.77) of antibiotics on the WHO Watch List administered in 2017. Antibiotic use increased annually by 4.09 DOT/1000 days (99% CI: 1.18, 6.99) before adjusting for resident factors, and 3.12 DOT/1000 days (99% CI: − 0.05, 6.29) after adjustment. Annual prevalence of antibiotic use decreased from 68.4% (99% CI: 66.9, 69.9) in 2015 to 63.4% (99% CI: 61.9, 65.0) in 2017, suggesting fewer residents were on antibiotics, but using them for longer. Resident factors associated with higher use were increasing age; chronic respiratory disease; a history of urinary tract infections, and skin and soft tissue infections; but dementia was associated with lower use. RAC home level antibiotic use ranged between 44.0 to 169.2 DOT/1000 days in 2016. Adjusting for resident factors marginally reduced this range (42.6 to 155.5 DOT/1000 days).

Conclusions

Antibiotic course length and RAC homes with high use should be a focus of antimicrobial stewardship interventions. Practices in RAC homes with low use could inform interventions and warrant further investigation. This study provides a model for using electronic health records as a data source for antibiotic use surveillance in RAC.
Appendix
Available only for authorised users
Literature
2.
go back to reference Marra F, McCabe M, Sharma P, et al. Utilization of antibiotics in long-term care facilities in British Columbia, Canada. J Am Med Dir Assoc. 2017;18(12):1098.e1–1098.e11.CrossRef Marra F, McCabe M, Sharma P, et al. Utilization of antibiotics in long-term care facilities in British Columbia, Canada. J Am Med Dir Assoc. 2017;18(12):1098.e1–1098.e11.CrossRef
3.
go back to reference Thornley T, Ashiru-Oredope D, Normington A, et al. Antibiotic prescribing for residents in long-term-care facilities across the UK. J Antimicrob Chemother. 2019;74(5):1447–51.CrossRefPubMedPubMedCentral Thornley T, Ashiru-Oredope D, Normington A, et al. Antibiotic prescribing for residents in long-term-care facilities across the UK. J Antimicrob Chemother. 2019;74(5):1447–51.CrossRefPubMedPubMedCentral
4.
go back to reference van Buul LW, van der Steen JT, Veenhuizen RB, et al. Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc. 2012;13(6):568.-e1–568. e13.CrossRef van Buul LW, van der Steen JT, Veenhuizen RB, et al. Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc. 2012;13(6):568.-e1–568. e13.CrossRef
8.
go back to reference Lind KE, Jorgensen ML, Gary LC, et al. Anti-osteoporosis medication use in a high fracture-risk population: contemporary trends in Australian residential aged care facilities; 2019. Lind KE, Jorgensen ML, Gary LC, et al. Anti-osteoporosis medication use in a high fracture-risk population: contemporary trends in Australian residential aged care facilities; 2019.
9.
go back to reference Lind KE, Gray LC, Raban MZ, Georgiou A, Westbrook JI. Antidementia medication use by aged care facility residents with dementia. Int J Geriatr Psychiatry. 2019;34:1024–40.CrossRef Lind KE, Gray LC, Raban MZ, Georgiou A, Westbrook JI. Antidementia medication use by aged care facility residents with dementia. Int J Geriatr Psychiatry. 2019;34:1024–40.CrossRef
10.
go back to reference Pont LG, Raban MZ, Jorgensen ML, et al. Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: variation in polypharmacy and antipsychotic use. International J Qual Health Care. 2018;30(10):810–6.CrossRef Pont LG, Raban MZ, Jorgensen ML, et al. Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: variation in polypharmacy and antipsychotic use. International J Qual Health Care. 2018;30(10):810–6.CrossRef
12.
go back to reference Lee BS, Bhuta T, Simpson JM, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):Cd003265.PubMed Lee BS, Bhuta T, Simpson JM, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):Cd003265.PubMed
13.
go back to reference Yang B, Blick C, Foley S. Avoiding antibiotics in the management of recurrent UTIs in women: what are our options? J Clin Urol. 2020;13(1):76–82.CrossRef Yang B, Blick C, Foley S. Avoiding antibiotics in the management of recurrent UTIs in women: what are our options? J Clin Urol. 2020;13(1):76–82.CrossRef
15.
go back to reference Australian Medicines Handbook. 2019, Adelaide: Australian Medicines Handbook Pty Ltd. Australian Medicines Handbook. 2019, Adelaide: Australian Medicines Handbook Pty Ltd.
20.
go back to reference Park RE. Estimation with Heteroscedastic error terms. Econometrica. 1966;34(4):888.CrossRef Park RE. Estimation with Heteroscedastic error terms. Econometrica. 1966;34(4):888.CrossRef
21.
go back to reference Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–37.CrossRefPubMed Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–37.CrossRefPubMed
22.
go back to reference Chatterjee A, Modarai M, Naylor NR, et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018;18(12):e368–78.CrossRefPubMed Chatterjee A, Modarai M, Naylor NR, et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018;18(12):e368–78.CrossRefPubMed
23.
go back to reference Stevens V, Dumyati G, Fine LS, et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42–8.CrossRefPubMed Stevens V, Dumyati G, Fine LS, et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42–8.CrossRefPubMed
24.
go back to reference Llewelyn MJ, Fitzpatrick JM, Darwin E, et al. The antibiotic course has had its day. BMJ. 2017;358:j3418. Llewelyn MJ, Fitzpatrick JM, Darwin E, et al. The antibiotic course has had its day. BMJ. 2017;358:j3418.
26.
go back to reference McGuire TM, Smith J, Del Mar C. The match between common antibiotics packaging and guidelines for their use in Australia. Aust N Z J Public Health. 2015;39(6):569–72.CrossRefPubMedPubMedCentral McGuire TM, Smith J, Del Mar C. The match between common antibiotics packaging and guidelines for their use in Australia. Aust N Z J Public Health. 2015;39(6):569–72.CrossRefPubMedPubMedCentral
27.
go back to reference Bennett N, Imam N, James R, et al. Prevalence of infections and antimicrobial prescribing in Australian aged care facilities: evaluation of modifiable and nonmodifiable determinants. Am J Infect Control. 2018;46(10):1148–53.CrossRefPubMed Bennett N, Imam N, James R, et al. Prevalence of infections and antimicrobial prescribing in Australian aged care facilities: evaluation of modifiable and nonmodifiable determinants. Am J Infect Control. 2018;46(10):1148–53.CrossRefPubMed
28.
go back to reference Daneman N, Campitelli MA, Giannakeas V, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ Can Med Assoc J. 2017;189(25):E851–60.CrossRef Daneman N, Campitelli MA, Giannakeas V, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ Can Med Assoc J. 2017;189(25):E851–60.CrossRef
29.
go back to reference Lim CJ, Kwong MW, Stuart RL, et al. Antibiotic prescribing practice in residential aged care facilities--health care providers' perspectives. Med J Aust. 2014;201(2):98–102.CrossRefPubMed Lim CJ, Kwong MW, Stuart RL, et al. Antibiotic prescribing practice in residential aged care facilities--health care providers' perspectives. Med J Aust. 2014;201(2):98–102.CrossRefPubMed
30.
go back to reference Cowan RU, Kishan D, Walton AL, et al. Cleaning, resistant bacteria, and antibiotic prescribing in residential aged care facilities. Am J Infect Control. 2016;44(3):e19–21.CrossRefPubMed Cowan RU, Kishan D, Walton AL, et al. Cleaning, resistant bacteria, and antibiotic prescribing in residential aged care facilities. Am J Infect Control. 2016;44(3):e19–21.CrossRefPubMed
31.
go back to reference Stuart RL, Orr E, Kotsanas D, et al. A nurse-led antimicrobial stewardship intervention in two residential aged care facilities. Healthcare Infection. 2015;20(1):4–6.CrossRef Stuart RL, Orr E, Kotsanas D, et al. A nurse-led antimicrobial stewardship intervention in two residential aged care facilities. Healthcare Infection. 2015;20(1):4–6.CrossRef
32.
go back to reference Smith M, Atkins S, Worth L, et al. Infections and antimicrobial use in Australian residential aged care facilities: a comparison between local and international prevalence and practices. Australian Health Rev. 2013;37(4):529–34.CrossRef Smith M, Atkins S, Worth L, et al. Infections and antimicrobial use in Australian residential aged care facilities: a comparison between local and international prevalence and practices. Australian Health Rev. 2013;37(4):529–34.CrossRef
33.
go back to reference Daneman N, Bronskill SE, Gruneir A, et al. Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med. 2015;175(8):1331–9.CrossRefPubMed Daneman N, Bronskill SE, Gruneir A, et al. Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med. 2015;175(8):1331–9.CrossRefPubMed
Metadata
Title
Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014–2017: a longitudinal analysis of electronic health record data
Authors
M. Z. Raban
K. E. Lind
R. O. Day
L. Gray
A. Georgiou
J. I. Westbrook
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Antibiotic
Care
Published in
BMC Health Services Research / Issue 1/2020
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-020-05723-3

Other articles of this Issue 1/2020

BMC Health Services Research 1/2020 Go to the issue